Surveillance after resection of pancreatic ductal adenocarcinoma: How to do it and what are the benefits?
Scand J Surg
; 113(2): 184-185, 2024 Jun.
Article
em En
| MEDLINE
| ID: mdl-38288556
ABSTRACT
BACKGROUND AND OBJECTIVE:
Surveillance following resection with curative intent of pancreatic cancer varies widely, and supporting evidence is limited. Recurrence is although frequent, not at least during the first 2 years. Surveillance may be costly, but evidence on how this influences overall survival is not fully elucidated. METHODS,RESULTS:
There are reports implying that signs of biological recurrence (increasing CA 19-9) precede radiologically demonstrated recurrence by months.CONCLUSIONS:
The possibility of initiating salvage therapy earlier is discussed, potentially based on improved future biomarker panels.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Pancreáticas
/
Carcinoma Ductal Pancreático
/
Recidiva Local de Neoplasia
Tipo de estudo:
Screening_studies
Limite:
Humans
Idioma:
En
Revista:
Scand J Surg
Ano de publicação:
2024
Tipo de documento:
Article